| Serial Number | 98919014 |
| Word Mark | EOS SENOLYTIX |
| Filing Date | Monday, December 23, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, February 5, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 24, 2026 |
| Description of Mark | The mark consists of the words EOS SENOLYTIX with a partial lemniscate in blue forming the letter 'X'. |
| Goods and Services | Anti-aging therapy; Medical services, namely, anti-aging services; Medical testing services, namely, biologic age scoring; Medical testing services in the nature of statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services, namely, biopsy services; Medical testing services, namely, biopsy services related to biologic age; Medical testing services, namely, biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, laboratory services related to biologic age; Laboratory services related to biological age scoring, namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, laboratory services related to determining a number or percentage of senescent cells; Non-invasive medical testing; Non-invasive medical testing related to biologic age; Non-invasive medical testing related to biological age scoring; Non-invasive medical testing related to determining a number or percentage of senescent cells; Medical care, namely prevention of radiation damage; Medical care, namely treatment of radiation damage; Medical care, namely, prevention of radiation related diseases; Medical care, namely, treatment of radiation related diseases; Medical care, namely, treatment of obesity; Providing weight loss program services in the nature of weight loss regimens; Medical care, namely, treatment of obesity in combination with other drugs |
| Goods and Services | Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Synthesized peptides for use in treating age-related diseases and cancer; Synthesized peptides for use in skin conditions; Synthesized peptides, namely anti-aging peptides; Synthesized peptides for use in prevention of radiation damage; Synthesized peptides for use in treatment of radiation damage; Synthesized peptides for use in prevention of radiation related diseases; Synthesized peptides for use in treatment of radiation related diseases; Synthesized peptides for use in treatment of obesity; Synthesized peptides for use in weight loss regimens, Synthesized peptides for use in treatment of obesity in combination with other drugs |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Goods and Services | Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, and development of pharmaceutical preparations for age therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; Anti-aging research; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders |
| NOT AVAILABLE | SENOLYTICS |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SENOTHERAPEUTIX, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Surfside, FL 33154 |
| Event Date | Event Description |
| Monday, December 23, 2024 | NEW APPLICATION ENTERED |
| Thursday, May 29, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 29, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, June 9, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, July 29, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 29, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 28, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, October 28, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, January 29, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 29, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 29, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 2, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |